Results 1 to 10 of about 13,181 (300)

Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System

Clinical Infectious Diseases, 2018
Jason Hickok, Poland Russell E
exaly  

Clostridium difficile classification overestimates hospital-acquired infections

Journal of Hospital Infection, 2018
Angus Mclure, Martyn D Kirk, Kathryn Glass   +2 more
exaly  

Postoperative antimicrobials after lung transplantation and the development of multidrug‐resistant bacterial and Clostridium difficile infections: an analysis of 500 non‐cystic fibrosis lung transplant patients

Clinical Transplantation, 2016
Kyle L Dawson, Katherine K Perez, Leif E Peterson   +2 more
exaly  

Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010

American Journal of Infection Control, 2015
Samuel L Aitken, Grace C Lee, Natalie K Boyd   +2 more
exaly  

Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm

Journal of Clinical Microbiology, 2018
Lauren M Dibiase, Jonathan J Juliano
exaly  

Fatal Clostridium difficile enteritis caused by the BI/NAP1/027 strain: a case series of ileal C. difficile infections

Clinical Microbiology and Infection, 2009
Jacques Pepin, S Dube
exaly  

Epidemiology of Clostridium difficile-associated infections

Clinical Microbiology and Infection, 2001
F Barbut, J C Petit
exaly  

Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority

International Journal of Environmental Research and Public Health, 2017
Laura Dallolio, Erica Leoni, Patrizia Farruggia   +2 more
exaly  

Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis

Journal of Hospital Infection, 2015
Jb Sarma
exaly  

Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections

Clinical Therapeutics, 2012
exaly